Transfusions of granulocyte-colony-stimulating factor-mobilized granulocyte components to allogeneic transplant recipients: Analysis of kinetics and factors determining posttransfusion neutrophil and platelet counts

Transfusion

Volumn 37, Issue 7, 1997, Pages 737-748

  Adkins, D ^a,b   Spitzer, G ^a,c   Johnston, M ^a   Velasquez, W ^a   Dunphy, F ^a   Petruska, P ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c LDS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CLINICAL ARTICLE; FEMALE; HODGKIN DISEASE; HUMAN; LEUKAPHERESIS; LEUKEMIA; LEUKOCYTE ACTIVATION; LEUKOCYTE COUNT; MALE; THROMBOCYTE COUNT; TREATMENT OUTCOME;

EID: 0030876964     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.1997.37797369451.x     Document Type: Article

References (71)

1. Bodey GP, Buckley M, Sathe YS, Freireich EJ. Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med 1966;64:328-40.
2. Clift RA, Buckner CD, Thomas ED, et al. Marrow transplantation for chronic myeloid leukemia: a randomized study comparing cyclophosphamide and total body irradiation with busulfan and cyclophosphamide. Blood 1994;84:2036-43.
3. Schriber JR, Chao NJ, Long GD, et al. Granulocyte colony-stimulating factor after allogeneic bone marrow transplantation. Blood 1994;84:1680-4.
4. De Witte T, Gratwohl A, Van Der Lely N, et al. Recombinant human granulocyte-macrophage colony-stimulating factor accelerates neutrophil and monocyte recovery after allogeneic T-cell-depleted bone marrow transplantation. Blood 1992;79:1359-65.
5. Powles R, Smith C, Milan S, et al. Human recombinant GM-CSF in allogeneic bone-marrow transplantation for leukaemia: double-blind, placebo-controlled trial. Lancet 1990;336:1417-20.
6. Nemunaitis J, Anasetti C, Storb R, et al. Phase II trial of recombinant human granulocyte-macrophage colony-stimulating factor in patients undergoing allogeneic bone marrow transplantation from unrelated donors. Blood 1992;79:2572-7.
7. Körbling M, Przepiorka D, Huh YO, et al. Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: potential advantage of blood over marrow allografts. Blood 1995;85:1659-65.
8. Bensinger WI, Weaver CH, Appelbaum FR, et al. Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor. Blood 1995;85:1655-8.
9. Schmitz N, Dreger P, Suttorp M, et al. Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by filgrastim (granulocyte colony-stimulating factor). Blood 1995;85:1666-72.
10. Appelbaum FR, Bowles CA, Makuch RW, Deisseroth AB. Granulocyte transfusion therapy of experimental Pseudomonas septicemia: study of cell dose and collection technique. Blood 1978;52:323-31.
11. Debelak KM, Epstein RB, Andersen BR. Granulocyte transfusions in leukopenic dogs: in vivo and in vitro function of granulocytes obtained by continuous-flow filtration leukopheresis. Blood 1974;43:757-66.
12. Epstein RB, Waxman FJ, Bennett BT, Andersen BR. Pseudomonas septicemia in neutropenic dogs. I. Treatment with granulocyte transfusions. Transfusion 1974;14:51-7.
13. Epstein RB, Clift RA, Thomas ED. The effect of leukocyte transfusions on experimental bacteremia in the dog. Blood 1969;34:782-90.
14. Westrick MA, Debelak-Fehir KM, Epstein RB. The effect of prior whole blood transfusion on subsequent granulocyte support in leukopenic dogs. Transfusion 1977;17:611-20.
15. Dale DC, Reynolds HY, Pennington JE, et al. Granulocyte transfusion therapy of experimental Pseudomonas pneumonia. J Clin Invest 1974;54:664-71.
16. Dale DC, Reynolds HY, Pennington JE, et al. Experimental Pseudomonas pneumonia in leukopenic dogs: comparison of therapy with antibiotics and granulocyte transfusions. Blood 1976;47:869-76.
17. Chow HS, Sarpel SC, Epstein RB. Pathophysiology of Candida albicans meningitis in normal, neutropenic, and granulocyte transfused dogs. Blood 1980;55:546-51.
18. Chow HS, Sarpel SC, Epstein RB. Experimental candidiasis in neutropenic dogs: tissue burden of infection and granulocyte transfusion effects. Blood 1982;59:328-33.
19. Epstein RB, Chow HS. An analysis of quantitative relationships of granulocyte transfusion therapy in canines. Transfusion 1981;21:360-2.
20. Clift RA, Sanders JE, Thomas ED, et al. Granulocyte transfusions for the prevention of infection in patients receiving bone-marrow transplants. N Engl J Med 1978;298:1052-7.
21. Winston DJ, Ho WG, Young LS, Gale RP. Prophylactic granulocyte transfusions during human bone marrow transplantation. Am J Med 1980;68:893-7.
22. Higby DJ, Yates JW, Henderson ES, Holland JF. Filtration leukapheresis for granulocyte transfusion therapy. Clinical and laboratory studies. N Engl J Med 1975;292:761-6.
23. Graw RG Jr, Herzig G, Perry S, Henderson ES. Normal granulocyte transfusion therapy: treatment of septicemia due to gram-negative bacteria. N Engl J Med 1972;287:367-71.
24. Herzig RH, Herzig GP, Graw RG Jr, et al. Successful granulocyte transfusion therapy for gram-negative septicemia. A prospectively randomized controlled study. N Engl J Med 1977;296:701-5.
25. Schwarzenberg L, Mathe G, DeGrouchy J, et al. White blood cell transfusions. Isr J Med Sci 1965;1:925.
26. Lowenthal RM, Grossman L, Goldman JM, et al. Granulocyte transfusions in treatment of infections in patients with acute leukaemia and aplastic anaemia. Lancet 1975;1:353-8.
27. Vallejos C, McCredie KB, Bodey GP, et al. White blood cell transfusions for control of infections in neutropenic patients. Transfusion 1975;15:28-33.
28. Strauss RG, Goedken MM, Maguire LC, et al. Gram-negative sepsis treated with neutrophils collected exclusively by intermittent flow centrifugation leukapheresis. Transfusion 1980;20:79-81.
29. Ambinder EP, Button GR, Cheung T, et al. Filtration versus gravity leukapheresis in febrile granulocytopenic patients: a randomized prospective trial. Blood 1981;57:836-41.
30. Dahlke MB, Keashen M, Alavi JB, et al. Granulocyte transfusions and outcome of alloimmunized patients with gram-negative sepsis. Transfusion 1982;22:374-8.
31. Vogler WR, Winton EF. A controlled study of the efficacy of granulocyte transfusions in patients with neutropenia. Am J Med 1977;63:548-55.
32. Higby DJ, Freeman A, Henderson ES, et al. Granulocyte transfusions in children using filter-collected cells. Cancer 1976;38:1407-13.
33. Alavi JB, Root RK, Djerassi I, et al. A randomized clinical trial of granulocyte transfusions for infection in acute leukemia. N Engl J Med 1977;296:706-11.
34. Maybee DA, Millan AP, Ruymann FB. Granulocyte transfusion therapy in children. South Med J 1977;70:320-4.
35. Fortuny IE, Bloomfield CD, Hadlock DC, et al. Granulocyte transfusion: a controlled study in patients with acute non-lymphocytic leukemia. Transfusion 1975;15:548-58.
36. Winston DJ, Ho WG, Gale RP. Therapeutic granulocyte transfusions for documented infections. A controlled trial in ninety-five infectious granulocytopenic episodes. Ann Intern Med 1982;97:509-15.
37. Higby DJ. Granulocyte transfusion: where now? (editorial) N Engl J Med 1981;305:636-8.
38. Higby DH, Burnette D. Granulocyte transfusions: current status. Blood 1980;55:2-8.
39. Dancey JT, Deubelbeiss KA, Harker LA, Finch CA. Neutrophil kinetics in man. J Clin Invest 1976;58:705-15.
40. Graw RG Jr, Goldstein IM, Eyre HJ, Terasaki PI. Histocompatibility testing for leucocyte transfusion. Lancet 1970;1:77-8.
41. Higby DJ, Mishler JM, Cohen E, et al. Increased elevation of peripheral leukocyte counts by infusion of histocompatible granulocytes. Vox Sang 1974;27:186-9.
42. French JE, Solomon JM, Fratantoni JC. Survey on the current use of leukapheresis and the collection of granulocyte concentrates. Transfusion 1982;22:220-5.
43. Boggs DR. Neutrophils in the blood bank (editorial). N Engl J Med 1977;296:748-50.
44. Strauss RG. Therapeutic granulocyte transfusions in 1993 (editorial). Blood 1993;81:1675-8.
45. Bensinger WI, Price TH, Dale DC, et al. The effects of daily recombinant human granulocyte colony-stimulating factor administration on normal granulocyte donors undergoing leukapheresis. Blood 1993;81:1883-8.
46. Caspar CB, Seger RA, Burger J, Gmur J. Effective stimulation of donors for granulocyte transfusions with recombinant methionyl granulocyte colony-stimulating factor. Blood 1993;81:2866-71.
47. MacPherson JL, Nusbacher J, Bennett JM. The acquisition of granulocytes by leukapheresis: a comparison of continuous flow centrifugation and filtration leukapheresis in normal and corticosteroid-stimulated donors. Transfusion 1976;16:221-8.
48. Shoji M, Vogler WR. Effects of hydrocortisone on the yield and bactericidal function of granulocytes collected by continuous-flow centrifugation. Blood 1974;44:435-43.
49. Begley CG, Lopez AF, Nicola NA, et al. Purified colony-stimulating factors enhance the survival of human neutrophils and eosinophils in vitro: a rapid and sensitive microassay for colony-stimulating factors. Blood 1986;68:162-6.
50. Colotta F, Re F, Polentarutti N, et al. Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products. Blood 1992;80:2012-20.
51. Liles WC, Rodger ER, Dale DC. In vivo administration of granulocyte colony-stimulating factor (G-CSF) to normal human subjects: priming of the respiratory burst and inhibition of apoptosis in neutrophils (abstract). Blood 1994;84:24a.
52. Colotta F, Re F, Mantovani A. Granulocyte transfusions from granulocyte colony-stimulating factor-treated donors: also a question of cell survival? (letter). Blood 1993;82:2258.
53. McCredie KB, Freireich EJ, Hester JP, Vallejos C. Increased granulocyte collection with the blood cell separator and the addition of etiocholanolone and hydroxyethyl starch. Transfusion 1974;14:357-64.
54. Price TH, Dale DC. Blood kinetics and in vivo chemotaxis of transfused neutrophils: effect of collection method, donor corticosteroid treatment, and short-term storage. Blood 1979;54:977-86.
55. Lee JH, Leitman SF, Klein HG. A controlled comparison of the efficacy of hetastarch and pentastarch in granulocyte collections by centrifugal leukapheresis. Blood 1995;86:4662-6.
56. Mishler JM, Hadlock DC, Fortuny IE, et al. Increased efficiency of leukocyte collection by the addition of hydroxyethyl starch to the continuous flow centrifuge. Blood 1974;44:571-81.
57. Appelbaum FR, Norton L, Graw RG Jr. Migration of transfused granulocytes in leukopenic dogs. Blood 1977;49:483-8.
58. Spitzer G, Adkins DR, Spencer V, et al. Randomized study of growth factors post-peripheral-blood stem-cell transplant: neutrophil recovery is improved with modest clinical benefit. J Clin Oncol 1994;12:661-70.
59. Freireich EJ, Levin RH, Whang J, et al. The function and fate of transfused leukocytes from donors with chronic myelocytic leukemia in leukopenic recipients. Ann N Y Acad Sci 1964;113:1081.
60. Morse EE, Freireich EJ, Carbone PP, et al. The transfusion of leukocytes from donors with chronic myelocytic leukemia to patients with leukopenia. Transfusion 1966;6:183-92.
61. Schiffer CA, Aisner J, Dutcher JP, Wiernik PH. Sustained post-transfusion granulocyte count increments following transfusion of leukocytes obtained from donors with chronic myelogenous leukemia. Am J Hematol 1983;15:65-74.
62. Levin RH, Whang J, Tjio JH, et al. Persistent mitosis of transfused homologous leukocytes in children receiving antileukemic therapy. Science 1963;142:1305.
63. Clarke K, Szer J, Shelton M, et al. Multiple granulocyte transfusions facilitating successful unrelated bone marrow transplantation in a patient with very severe aplastic anemia complicated by suspected fungal infection. Bone Marrow Transplant 1995;16:723-6.
64. Schiffer CA, Aisner J, Daly PA, et al. Alloimmunization following prophylactic granulocyte transfusion. Blood 1979;54:766-74.
65. Kerst JM, de Haas M, van der School CE, et al. Recombinant granulocyte colony-stimulating factor administration to healthy volunteers: induction of immunophenotypically and functionally altered neutrophils via an effect on myeloid progenitor cells. Blood 1993;82:3265-72.
66. Adkins D, Goodgold H, Hendershott L, et al. Indium-labeled white blood cells (WBC) obtained from bone marrow donors receiving granulocyte colony stimulating factor (G-CSF) localize to sites of inflammation when infused into allogeneic bone marrow transplant (Allo-BMT) recipients (abstract). Blood 1995;86:582a.
67. Bishop JF, McGrath K, Wolf MM, et al. Clinical factors influencing the efficacy of pooled platelet transfusions. Blood 1988;71:383-7.
68. Moroff G, Garratty G, Heal JM, et al. Selection of platelets for refractory patients by HLA matching and prospective cross-matching. Transfusion 1992;32:633-40.
69. Murphy S. Preservation and clinical use of platelets. In: Williams WJ, Beutler E, Erslev AJ, Lichtman MA, eds. Hematology. 4th ed. New York: McGraw-Hill, 1990:1654-9.
70. Liles WC, Dale DC, Klebanoff SJ. Glucocorticoids inhibit apoptosis of human neutrophils. Blood 1995;86:3181-8.
71. 4A and adenosine triphosphate interact with granulocyte-macrophage colony-stimulating factor to delay neutrophil apoptosis: implications for neutrophil:platelet interactions during inflammation. Blood 1996;87:3442-9.